Tumefactive multiple sclerosis masquerade as a central nervous system tumor
A case report
Keywords:
Tumevactive demyelinating lesions (TDLs), CSF, OCB, MRI, CNS tumorsAbstract
Introduction: Tumefactive multiple sclerosis is a demyelinating disorder that appears tumor-like on MRI. To most physicians, diagnosing tumefactive MS by applying clinical, radiological, or laboratory examination like Cerebrospinal fluid (CSF) analysis, can be challenging and ultimately biopsy is necessary to confirm the diagnosis. Case presentation: This paper reports a case of a 37-year-old woman who presented with progressive headache and a strong family history of cancer and was misdiagnosed as having a CNS glioma. After considering the MRI features, CSF analysis results and observing improvement with IV steroids, the diagnosis of tumefactive MS was made. The patient refused biopsy to rule out the possibility of tumor or abscess. Nine months later, she presented with another relapse and an injectable disease modifying treatment (DMT) was initiated, and her course has been stable in follow up. Take-away lesson: The overall clinical importance of this case report is to highlight the real possibility of being forced to decide between Tumefactive demyelinating lesions (TDLs) and brain tumors in clinical practice, in order to avoid unnecessary biopsy.References
Lucchinetti C, Gavrilova R, Metz I, Parisi JE, Scheithauer BW, Weigand S, et al. Clinical and radiographic
spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008; 131(7): 1759-75. doi:
1093/brain/awn098.
Kiriyama T, Kataoka H, Taoka T, Tonomura Y, Terashima M, Morikawa M, et al. Characteristic
Neuroimaging in Patients with Tumefactive Demyelinating Lesions Exceeding 30 mm. J Neuroimaging.
; 21(2): e69-77. doi: 10.1111/j.1552-6569.2010.00502.x. PMID: 20572907.
Kaeser M, Scali F, Lanzisera F, Bub G, Kettner N. Tumefactive multiple sclerosis: an uncommon
diagnostic challenge. J Chiropr Med. 2011; 10(1): 29-35. doi: 10.1016/j.jcm.2010.08.002. PMID:
, PMCID: PMC3110404.
Ünver O, Hasıloğlu ZI, Durak U, Uysal S. A Tumefactive Multiple Sclerosis Case Mimicking a Focal
Cerebral Mass. Cukurova Med J. 2013; 38(2): 329-32.
Peterson K, Rosenblum M, Powers J, Alvord E, Walker R, Posner J. Effect of brain irradiation on
demyelinating lesions. Neurology. 1993; 43(10): 2105. doi: 10.1212/wnl.43.10.2105.
Brant WE, Helms CA. Fundamentals of diagnostic radiology. Philadelphia: Lippincott, Williams &
Wilkins; 2007.
A Clinical Presentation of Tumefactive Multiple Sclerosis Mimicking Acute Ischemic Stroke on MRI.
Journal of Experimental and Clinical Neurosciences. 2014. doi: 10.13183/jecns.v1i1.1.
Kim DS, Na DG, Kim KH, Kim JH, Kim E, Yun BL, et al. Distinguishing tumefactive demyelinating
lesions from glioma or central ner- vous system lymphoma: added value of unenhanced CT com- pared
with conventional contrast-enhanced MR imaging. Radiology. 2009; 251(2): 467-75. doi:
1148/radiol.2512072071. PMID: 19261924.
Law M, Meltzer D, Cha S. Spectroscopic magnetic resonance imaging of a tumefactive demyelinating
lesion. Neuroradiology. 2002; 44(12): 986-9. doi: 10.1007/s00234-002-0872-1.
Kim DS, Na DG, Kim KH, Kim JH, Kim E, Yun BL, et al. Distinguishing Tumefactive Demyelinating
Lesions from Glioma or Central Nervous System Lymphoma: Added Value of Unenhanced CT Compared
with Conventional Contrast-enhanced MR Imaging. Radiology. 2009; 251(2): 467-75. doi:
1148/radiol.2512072071. PMID: 19261924.
Yamada S, Yamada SM, Nakaguchi H, Murakami M, Hoya K, Matsuno A, et al. Tumefactive multiple
sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report. J
Med Case Rep. 2012; 6: 104. doi: 10.1186/1752-1947-6-104. PMID: 22483341, PMCID: PMC3337287.
Butteriss D, Ismail A, Ellison D, Birchall D. Use of serial proton magnetic resonance spectroscopy to
differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol.
; 76(909): 662-5. doi: 10.1259/bjr/85069069. PMID: 14500284.
Kepes J. Large focal tumor-like demyelinating lesions of the brain: Intermediate entity between multiple
sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Annals of Neurology. 1993;
(1): 18-27. doi: 10.1002/ana.410330105.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.